Viewing Study NCT06940960


Ignite Creation Date: 2025-12-25 @ 2:07 AM
Ignite Modification Date: 2025-12-26 @ 5:46 AM
Study NCT ID: NCT06940960
Status: RECRUITING
Last Update Posted: 2025-06-10
First Post: 2025-03-27
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: JY231(JY231) Injection for the Treatment of Relapsed/Refractory B Cell Lymphoma/ Leukemia
Sponsor: Affiliated Hospital of Guangdong Medical University
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2025-05-30
Start Date Type: ACTUAL
Primary Completion Date: 2027-12
Primary Completion Date Type: ESTIMATED
Completion Date: 2027-12
Completion Date Type: ESTIMATED
First Submit Date: 2025-03-27
First Submit QC Date: None
Study First Post Date: 2025-04-23
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2025-06-05
Last Update Post Date: 2025-06-10
Last Update Post Date Type: ACTUAL